Clinical Trial Update: A Phase 2 Trial to Evaluate the Efficacy and Safety of Linezolid in Tuberculosis Patients. (LIN-CL001) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of linezolid in patients with pulmonary tuberculosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• Linezolid (Linezolid)

Snippet

Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED